Cyclo Therapeutics Stock Analysis

Cyclo Stock Analysis Notes

The company had not issued any dividends in recent years. Cyclo Therapeutics, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Cyclo Therapeutics, Inc. was founded in 1990 and is based in Gainesville, Florida. Cyclo Therapeutics is traded on NASDAQ Exchange in the United States. For more info on Cyclo Therapeutics please contact Scott Fine at 386 418 8060 or go to https://cyclotherapeutics.com.

Cyclo Therapeutics Investment Alerts

Cyclo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 62.76 M.

Cyclo Profitablity

Management Efficiency

Cyclo Therapeutics has return on total asset (ROA) of (2.8249) % which means that it has lost $2.8249 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (226.6391) %, meaning that it generated substantial loss on money invested by shareholders. Cyclo Therapeutics' management efficiency ratios could be used to measure how well Cyclo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -1.65 in 2025. Return On Capital Employed is likely to climb to -4.58 in 2025. At this time, Cyclo Therapeutics' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 3.3 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 32.8 K in 2025.

Technical Drivers

As of the 1st of February, Cyclo Therapeutics shows the mean deviation of 8.57, and Risk Adjusted Performance of 0.125. Cyclo Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cyclo Therapeutics market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Cyclo Therapeutics is priced correctly, providing market reflects its regular price of 0.3 per share. As Cyclo Therapeutics appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Cyclo Therapeutics Price Movement Analysis

Cyclo Therapeutics Insider Trading Activities

Cyclo Therapeutics Predictive Daily Indicators

Cyclo Therapeutics Forecast Models

Cyclo Therapeutics' time-series forecasting models are one of many Cyclo Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cyclo Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cyclo Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cyclo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cyclo Therapeutics. By using and applying Cyclo Stock analysis, traders can create a robust methodology for identifying Cyclo entry and exit points for their positions.

When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.